| Literature DB >> 12216337 |
.
Abstract
A combined oral contraceptive (COC) containing the progestogen drospirenone (pronounced dro-spi-re-known) plus the oestrogen ethinylestradiol ([symbol: see text] Yasmin--Schering Health Care) is now available in the UK. Company advertising claims that Yasmin is "truly different", as reliable and safe as other COCs and is "the pill for well-being", with "no associated weight gain" and "a demonstrable positive effect" on premenstrual symptoms and skin condition. Such claims have also appeared in the lay media. Are they justified?Entities:
Mesh：
Substances：
Year: 2002 PMID： 12216337
Source DB: PubMed Journal: Drug Ther Bull ISSN： 0012-6543